The honey bee \[*Apis mellifera* L. (Hymenoptera: Apidae)\] plays an important role in satisfying human food and fiber needs. The annual value of pollination services provided by honey bees in the United States exceeds \$14 billion ([@CIT0027]), while the global contribution of pollinators to food production is estimated at more than \$200 billion ([@CIT0016]). Furthermore, an estimated 35% of the food consumed by humans comes from crops that depend on pollinators, and 52 of the 115 leading global food commodities are dependent on honey bee pollination for either fruit or seed set ([@CIT0020]). Unfortunately, the benefits provided by honey bees in the United States are being threatened by ongoing high rates of mortality among managed colonies ([@CIT0008]), which have declined by about 60% between 1947 and 2008 ([@CIT0011], [@CIT0012]). These losses are being driven by a wide range of interrelated factors, at the heart of which is the idea that external stressors such as parasite pressure, pesticide exposure, and poor nutrition reduce immunocompetence and subsequently increase pathogen loads ([@CIT0018], [@CIT0032]).

The ectoparasitic mite *Varroa destructor* (Parasitiformes: Varroidae), which can produce significant detrimental effects on colony health if left untreated ([@CIT0006], [@CIT0003], [@CIT0041]), is the primary target for beekeeper-applied acaricides, which are among the most common contaminants of the hive environment ([@CIT0009], [@CIT0028], [@CIT0025]). The two most commonly detected acaricides are the pyrethroid *tau*-fluvalinate (Apistan) and the organophosphate coumaphos (CheckMite+) ([@CIT0028]). As a pyrethroid insecticide, *tau*-fluvalinate alters the gating kinetics of voltage-gated sodium channels, disrupting the propagation of action potentials in the cholinergic nervous system ([@CIT0029]), while the organophosphate coumaphos prevents the hydrolysis of acetylcholine, causing continual stimulation of the neuron and eventual paralysis of the insect ([@CIT0015]). Both acaricides are lipophilic compounds that are readily absorbed by beeswax ([@CIT0004]) and have previously been reported to negatively impact bee immunocompetence ([@CIT0005], [@CIT0026]). Consequently, the overall goal of the work presented here is to investigate the effects of *tau*-fluvalinate and coumaphos on biochemical and morphological indicators of bee nutrition, immunity, and development.

The health of a bee colony can be assessed in a number of different ways, but perhaps the most straightforward approach is to measure the nutritional state of individual bees within the colony. Bee nutrition has long been studied in terms of the major macronutrient profiles, which directly correlate to the dietary requirements of bees ([@CIT0019]). Nutrition is also understood to have an important impact on honey bee sensitivity to pesticides ([@CIT0039]), as well as immunocompetence ([@CIT0001], [@CIT0034], [@CIT0010]), possibly as a result of ion channel regulation of immunity driven by metabolic changes ([@CIT0031]). Colony immunocompetence is determined by both individual- and colony-level immune responses. One common measure of individual immunity is the enzyme phenoloxidase (POX), which is responsible for elements of the cellular immune response such as melanization, wound healing, and sclerotization ([@CIT0023]) and has been shown to increase in bees faced with an immune challenge ([@CIT0050], [@CIT0022]). Colony-level immunity, also known as social immunity, includes behavioral, physiological, and organizational adaptations such as hygienic behavior, necrophoric behavior, nest architecture, the use of propolis in the colony, and glucose oxidase (GOX) production ([@CIT0037], [@CIT0013]). GOX, which is produced in the hypopharyngeal gland to catalyze hydrogen peroxide production for the sterilization of hive products and honey, is a commonly used indicator of colony-level immunity ([@CIT0001]). Here, we report the effects of *tau*-fluvalinate and coumaphos exposure on markers of nutrition, immunity, and growth of the honey bee by describing changes in: 1) total proteins; 2) total carbohydrates; 3) total lipids; 4) POX activity; 5) GOX activity; and 6) body weight, head width, and wing length of nurse and forager bees from treated and untreated colonies.

Materials and Methods {#s1}
=====================

Reagents {#s2}
--------

Anthrone, [l]{.smallcaps}-dopa, and vanillin reagents were purchased from Acros Organics (New Jersey). Bicinchoninic acid, chloroform, copper sulfate, sulfuric acid, Triton X-100, and glucose were purchased from Sigma Aldrich (St. Louis, MO). Chymotrypsin and *o*-dianisidine were purchased from MP Biomedicals (Solon, OH). Horseradish peroxidase was purchased from Novex Life Technologies (Grand Island, NY). Coumaphos (CheckMite) was purchased from Bayer CropScience (RTP, NC) and *tau*-fluvalinate (Apistan) was purchased from Zoecon (Charlotte, NC).

Experimental Colonies and Bee Marking {#s3}
-------------------------------------

Nine experimental honey bee colonies were established in May at each of the three apiaries maintained by the Department of Entomology at Virginia Tech (a total of 27 colonies) and allowed to reach colony strength by June, approximately 6 wks following establishment. Each of the 27 experimental colonies consisted of a single-story hive constructed using new frames and foundation to limit pesticide pre-exposure; however, given that wax foundation is typically made from recycled commercial beeswax, it is possible that some pesticide contaminants were present. Each hive was also provided with a sister queen to reduce genetic variation among the colonies. Nine colonies were assigned to each of the three treatments (see Experimental Treatments) with the treatments allocated evenly among hives at the three apiaries. In order to reduce variability due to the age of the bees selected for analysis, age-matched adult bees were obtained by removing two random frames of brood from each colony. The frames were caged and housed in an incubator at 34°C with a 50--80% RH for 8 h, during which time adult bees emerged from the brood frames. Groups of approximately 100 bees were marked after emergence using Testors model paint and then smoked with pine needle smoke to eliminate paint odors before the bees were returned to their respective hives. This process was repeated periodically to ensure that marked groups of the appropriate age were available.

Experimental Treatments {#s4}
-----------------------

Colonies at each apiary received one of three treatments: 1) untreated control (no acaricide), 2) *tau*-fluvalinate (Apistan, Zoecon), or 3) coumaphos (CheckMite+, Bayer CropScience). For the *tau*-fluvalinate and coumaphos treatments, colonies were treated with either two *tau*-fluvalinate-impregnated strips (10.25% active ingredient each) or two coumaphos-impregnated strips (10.00% active ingredient each) for 6 wks according to the manufacturer's label recommendations. Following the 6-wk treatment period, samples of marked bees from two age groups, nurse and forager bees, were collected. Nurse bees were collected from the brood nest and forager bees from the hive entrance of each colony. Samples consisted of a minimum of 20 bees to ensure that five individuals from each hive were available for protein, carbohydrate, and lipid analysis, five individuals for POX and GOX activity, and 10 individuals for morphometric measurements. Bee samples were frozen in liquid nitrogen and stored at −80°C until analysis. Analysis of total proteins, carbohydrates, lipids, POX activity, and GOX activity was conducted using 45 bees and morphometric measurements were conducted using 90 bees.

Biochemical and Morphological Measurements {#s5}
------------------------------------------

### Total Protein {#s6}

The concentration of total proteins in sampled bees was measured according to the method of Smith et al. ([@CIT0036]), with modifications. Individual bees were homogenized in 1 ml of ice-cold 0.1 M sodium phosphate (pH 7.8) containing 0.3% Triton X-100 using a glass/teflon tissue homogenizer. Homogenates were centrifuged at 10,000 × *g* for 10 min at 4°C and the supernatants were transferred to clean 1.5 ml microcentrifuge tubes. Ten microliters of each supernatant were added to an individual well of a 96-well microplate containing 10 μl of 0.1 M sodium phosphate (pH 7.8) and 180 μl of bicinchoninic acid with 4% (v/v) copper sulfate. Samples were incubated for 30 min at 37°C and then cooled to room temperature for 5 min. The total protein content in each sample was measured at 560 nm using a Molecular Devices SpectraMax M2 multimode microplate reader (Sunnyvale, CA). The optical densities of the protein samples were compared with those measured for a bovine serum albumin protein standard. The *R*^2^ value for the equation was 0.99.

### Total Carbohydrates {#s7}

The concentration of total carbohydrates in sampled bees was measured according to the method of Van Handel and Day ([@CIT0038]), with modifications. Individual bees were homogenized in 1 ml of ice-cold 0.1 M sodium phosphate (pH 7.8) containing 0.3% Triton X-100 using a glass/teflon tissue homogenizer. Homogenates were centrifuged at 10,000 × *g* for 10 min at 4°C and the supernatants were transferred to clean 1.5 ml microcentrifuge tubes. Twenty microliters of each supernatant were added to a clean 5 ml glass centrifuge tube containing 1.98 ml of anthrone reagent. Samples were incubated at 90°C for 15 min and then cooled at room temperature. Two hundred microliters of each sample were added to an individual well of a 96-well microplate. The total carbohydrate content in each sample was measured at 625 nm using a Molecular Devices SpectraMax M2 multimode microplate reader. The optical densities of the carbohydrate samples were compared with those measured for a glucose carbohydrate standard. The *R*^2^ value for the equation was 0.99.

### Total Lipids {#s8}

The concentration of total lipids in sampled bees was measured according to the method of Van Handel and Day ([@CIT0038]), with modifications. Individual bees were homogenized in 1 ml of ice-cold 0.1 M sodium phosphate (pH 7.8) containing 0.3% Triton X-100 using a glass/teflon tissue homogenizer. Homogenates were centrifuged at 10,000 × *g* for 10 min at 4°C and the supernatants were transferred to clean 1.5 ml microcentrifuge tubes. Twenty microliters of each supernatant were added to a clean 5 ml glass centrifuge tube containing 200 μl of chloroform and 200 μl of sulfuric acid. The lipid samples were incubated at 90°C for 10 min followed by the addition of vanillin. Samples were then cooled at room temperature. Two hundred microliters of each sample were added to an individual well of a 96-well microplate. The total lipid content in each sample was measured at 625 nm using a Molecular Devices SpectraMax M2 multimode microplate reader. The optical densities of the lipid samples were compared with those measured for a vegetable oil standard. The *R*^2^ value for the equation was 0.99.

### POX Activity {#s9}

POX activity in sampled bees was measured according to the method of Laughton and Siva-Jothy ([@CIT0022]), with modifications. Using 1 μl capillary tubes, 2 μl hemolymph were collected from the fourth abdominal tergite of each individual honey bee and diluted in ice-cold 0.1 M sodium phosphate (pH 7.8) containing 0.3% Triton X-100. Nine microliters of diluted hemolymph were added to the individual well of a 96-well microplate containing 20 μl 0.1 M sodium phosphate (pH 7.8) and 135 μl deionized H~2~O. Five microliters of chymotrypsin were added to the wells. Samples were incubated for 5 min at 37°C followed by the addition of 20 μl [l]{.smallcaps}-dopa. POX activity was measured at 490 nm for 60 min at 15 s intervals on a Molecular Devices SpectraMax M2 multimode microplate reader. Activity was recorded as the change in optical density over time (ΔmOD) and standardized using the total protein concentration for each hemolymph sample. The total protein concentration was determined as described above using a bovine serum albumin standard.

### GOX Activity {#s10}

GOX activity in sampled bees was measured according to the method of [@CIT0002], with modifications. Heads were dissected from individual bees and homogenized in 1 ml of ice-cold 0.1 M sodium phosphate (pH 7.8) containing 0.3% Triton X-100 using a glass/teflon tissue homogenizer. Homogenates were centrifuged at 10,000 × *g* for 10 min at 4°C and the supernatants were transferred to clean 1.5 ml microcentrifuge tubes. Fifty microliters of each supernatant were added to an individual well of a 96-well microplate containing 0.5 M potassium phosphate (pH 7.0), 0.1 M glucose, and 2.5 U of horseradish peroxidase. Samples were incubated for 10 min at 37°C followed by the addition of 3 mM *O*-dianisidine. GOX activity was measured at 430 nm for 90 min at 15 s intervals on a Molecular Devices SpectraMax M2 multimode microplate reader. Activity was recorded as the change in optical density over time (ΔmOD) and standardized using the total protein concentration for each sample. The total protein concentration was determined as described above using a bovine serum albumin standard.

### Head Width, Wing Length, and Body Mass {#s11}

Morphometric measurements of the sampled bees were conducted according to the method of [@CIT0040]. The total body weight (wet weight) of individual bees was measured to the nearest milligram using a Mettler AE 100 analytical balance (Mettler, Toledo). The head width (mm) and forewing length (mm) of individual bees were measured using a Dinolite Pro AM413T/AD413T.

Statistical Analysis {#s12}
--------------------

All calculations and statistical analyses were carried out using GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA). Caste differences in total proteins, carbohydrates, lipids, POX, GOX activities, and morphometrics for each acaricide treatment were statistically compared to untreated controls using a two-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison test ([@CIT0042]). All statistical tests were carried out at a significance level (α) of 0.05.

Results {#s13}
=======

Total Proteins {#s14}
--------------

The total protein concentration of nurse and forager honey bees treated with *tau*-fluvalinate or coumaphos is shown in [Fig. 1A](#F1){ref-type="fig"}. No significant interaction due to caste was detected (*F* = 2.677; df = 1, 264; *P* = 0.1030), but a significant interaction due to treatment was observed (*F* = 10.89; df = 2, 264; *P* \< 0.0001). The total protein concentration of nurse bees was significantly lowered following exposure to *tau*-fluvalinate (13.50%; *P* = 0.0206), as well as coumaphos (15.13%; *P* = 0.0083), relative to untreated controls. The total protein concentration of forager bees was also significantly lowered following exposure to *tau*-fluvalinate (22.76%; *P* \< 0.0001), but was not significantly altered following exposure to coumaphos (2.03%; *P* = 0.9137), relative to untreated controls.

![Nutritional analysis showing (A) total protein, (B) total carbohydrate, and (C) total lipid content of nurse and forager honey bees following exposure to *tau*-fluvalinate (Apistan, 10.25% a.i.) or coumaphos (CheckMite+, 10.00% a.i.), compared with an untreated control. Bars represent mean protein level (µg/ml) ± SD (*n* = 45). Asterisks denote that the means are significantly different from the respective untreated control according to a two-way ANOVA and Dunnett's multiple comparison test where *P* \< 0.05 was considered significant.](iey08601){#F1}

Total Carbohydrates {#s15}
-------------------

The total carbohydrate concentration of nurse and forager honey bees treated with *tau*-fluvalinate or coumaphos is shown in [Fig. 1B](#F1){ref-type="fig"}. A significant interaction due to both caste (*F* = 4.341; df = 1, 261; *P* = 0.0382) and treatment (*F* = 17.62; df = 2, 261; *P* \< 0.0001) was observed. The total carbohydrate concentration of nurse bees was significantly lowered following exposure to *tau*-fluvalinate (20.10%; *P* = 0.0399), but was not significantly altered following exposure to coumaphos (11.46%; *P* = 0.3124), relative to untreated controls. The total carbohydrate concentration of forager bees, however, was significantly lowered following exposure to *tau*-fluvalinate (45.36%; *P* \< 0.0001), as well as coumaphos (37.02%; *P* \< 0.0001), relative to untreated controls.

Total Lipids {#s16}
------------

The total lipid concentration of nurse and forager honey bees treated with *tau*-fluvalinate or coumaphos is shown in [Fig. 1C](#F1){ref-type="fig"}. No significant interaction due to either caste (*F* = 0.4409; df = 1, 264; *P* = 0.5073) or treatment (*F* = 0.2832; df = 2, 264; *P* = 0.7536) was detected. The total lipid concentration of nurse bees was not significantly altered following exposure to either *tau*-fluvalinate (5.27%; *P* = 0.7508) or coumaphos (6.97%; *P* = 0.6128), nor was the total lipid concentration of forager bees significantly altered following exposure to either *tau*-fluvalinate (11.53%; *P* = 0.2389) or coumaphos (5.49%; *P* = 0.7022), relative to untreated controls.

POX Activity {#s17}
------------

POX activity of nurse and forager honey bees treated with *tau*-fluvalinate or coumaphos is shown in [Fig. 2A](#F2){ref-type="fig"}. No significant interaction due to either caste (*F* = 1.724; df = 1, 261; *P* = 0.1904) or treatment (*F* = 0.6670; df = 2, 261; *P* = 0.5141) was detected. POX activity of nurse bees was not significantly altered following exposure to either *tau*-fluvalinate (18.92%; *P* = 0.5683) or coumaphos (19.05%; *P* = 0.5640), nor was POX activity of forager bees significantly altered following exposure to either *tau*-fluvalinate (21.82%; *P* = 0.2743) or coumaphos (2.56%; *P* = 0.9802), relative to untreated controls.

![Analysis of immune responsiveness showing (A) total POX and (B) total GOX activity of nurse and forager honey bees following exposure to *tau*-fluvalinate (Apistan, 10.25% a.i.) or coumaphos (CheckMite+, 10.00% a.i.), compared with an untreated control. Bars represent mean activity level (ΔmOD/mg protein) ± SD (*n* = 45). Asterisks denote that the means are significantly different from the respective untreated control according to a two-way ANOVA and Dunnett's multiple comparison test where *P* \< 0.05 was considered significant.](iey08602){#F2}

GOX Activity {#s18}
------------

GOX activity of nurse and forager honey bees treated with *tau*-fluvalinate or coumaphos is shown in [Fig. 2B](#F2){ref-type="fig"}. A significant interaction due to both caste (*F* = 7.586; df = 1, 262; *P* = 0.0063) and treatment (*F* = 11.50; df = 2, 262; *P* \< 0.0001) was observed. GOX activity of nurse bees was not significantly altered following exposure to *tau*-fluvalinate (13.71%; *P* = 0.5698), but was significantly higher following exposure to coumaphos (45.94%; *P* = 0.5683), relative to untreated controls. GOX activity of forager bees was significantly higher following exposure to *tau*-fluvalinate (50.51%; *P* = 0.0010), as well as coumaphos (51.68%; *P* = 0.0006), relative to untreated controls.

Body Weight, Head Width, and Wing Length {#s19}
----------------------------------------

The results of the morphometric measurements of nurse and forager honey bees treated with *tau*-fluvalinate or coumaphos are shown in [Fig. 3A--C](#F3){ref-type="fig"}. For body weight, a significant interaction due to caste was observed (*F* = 17.99; df = 1, 534; *P* \< 0.0001), but no significant interaction due to treatment was detected (*F* = 1.512; df = 2, 534; *P* = 0.2214). Relative to untreated controls, the body weight of nurse bees was significantly higher following exposure to *tau*-fluvalinate (7.77%; *P* = 0.0110), but was unchanged following exposure to coumaphos (1.68%; *P* = 0. 7798) ([Fig. 3A](#F3){ref-type="fig"}). Likewise, the body weight of forager bees was significantly lower following exposure to *tau*-fluvalinate (12.83%; *P* \< 0.0001), but was unchanged following exposure to coumaphos (1.39%; *P* = 0.7932) ([Fig. 3A](#F3){ref-type="fig"}).

![Morphometric analysis showing (A) body weight, (B) head width, and (C) wing length of nurse and forager honey bees exposed to *tau*-fluvalinate (Apistan, 10.25% a.i.) or coumaphos (CheckMite+, 10.00% a.i.), compared with an untreated control. Bars represent mean body weight (mg), head width (mm), or wing length (mm) ± SD (*n* = 90). Asterisks denote that the means are significantly different from the respective untreated control according to a two-way ANOVA and Dunnett's multiple comparison test where *P* \< 0.05 was considered significant.](iey08603){#F3}

For head width, no significant interaction due to caste was detected (*F* = 0.2259; df = 1, 534; *P* = 0.6347), but a significant interaction due to treatment was observed (*F* = 21.49; df = 2, 534; *P* \< 0.0001). Relative to untreated controls, the head width of nurse bees was significantly decreased following exposure to *tau*-fluvalinate (2.52%; *P* \< 0.0001), but was unchanged following exposure to coumaphos (0.94%; *P* = 0. 2015) ([Fig. 3B](#F3){ref-type="fig"}). Likewise, the head width of forager bees was significantly decreased following exposure to *tau*-fluvalinate (2.24%; *P* = 0.0003), but was unchanged following exposure to coumaphos (0.92%; *P* = 0.2129) ([Fig. 3B](#F3){ref-type="fig"}).

For wing length, no significant interaction due to caste was detected (*F* = 2.693; df = 1, 534; *P* = 0.1013), but a significant interaction due to treatment was observed (*F* = 57.16; df = 2, 534; *P* \< 0.0001). Relative to untreated controls, wing length was significantly decreased in nurse bees following exposure to *tau*-fluvalinate (2.62%; *P* \< 0.0001), but was significantly increased in nurse bees following exposure to coumaphos (2.48%; *P* \< 0.0001). Likewise, wing length was significantly decreased in nurse bees following exposure to *tau*-fluvalinate (1.64%; *P* = 0.0048), but was significantly increased following exposure to coumaphos (1.85%; *P* = 0.0014) ([Fig. 3C](#F3){ref-type="fig"}).

Discussion {#s20}
==========

There are numerous stressors that negatively impact honey bee health and immunocompetence, including exposure to pesticides ([@CIT0032]), as well as the presence of the ectoparasitic mite *V. destructor*. By directly feeding on bees throughout their life cycle, mites reduce the overall health and immune responsiveness of the insect, in addition to facilitating the spread of pathogens and causing previously covert infections to become devastating outbreaks ([@CIT0017], [@CIT0024], [@CIT0030], [@CIT0035]). At this time, however, the most effective strategy for controlling mite populations is the use of chemical interventions. An extensive survey of managed bee colonies in North America detected a wide range of agricultural and apicultural pesticides contaminating the hive environment, among the most common of which were the beekeeper-applied acaricides *tau*-fluvalinate (Apistan) and coumaphos (CheckMite+) ([@CIT0028]). Although *tau*-fluvalinate and coumaphos have been found to be less efficacious in recent years as a result of increasing metabolic and target-site resistance in *Varroa* populations ([@CIT0033]), their high prevalence is likely due to a combination of their continued use by beekeepers and their lipophilic nature, which allows them to persist in beeswax ([@CIT0004]).

The results of this study show that *tau*-fluvalinate and coumaphos exposure had an impact on indicators of bee nutrition, evident in reduced protein levels and carbohydrate levels, on social immunity, evident through increased GOX activity, and on growth and development, evident through altered body weight, head width, and wing length. Low macronutrient concentrations have been associated with decreased colony population growth ([@CIT0043]); reduced worker lifespan ([@CIT0021]); and impairment of energy-intensive tasks such as flight, thermoregulation, and comb building ([@CIT0007]). Not surprisingly, nutritionally deficient bees also display signs of impaired growth and development when assessing general morphometric indicators. These results, in particular as they relate to *tau*-fluvalinate, stand in contrast to previously reported studies showing that *tau*-fluvalinate did not have an effect on body weight or protein and carbohydrate levels in treated bees ([@CIT0014]). The differences in the observed results are possibly due to genetic and/or age-related variation, as the previous study did not establish colonies using sister queens, nor were the sampled bees age-matched. The observed increases in GOX activity suggest that exposure to these acaricides is potentially inducing a social immune response. Interestingly, GOX levels previously have been shown to decrease in the presence of a neonicotinoid pesticide ([@CIT0002]), which could be due to either the different modes of action, or differences in experimental design.

In the effort to understand the factors that influence honey bee health, it is generally understood that interactions between pesticide exposure, mite stress, limits to nutrition, and immune challenges are all factors that contribute to colony stress and can decrease overall colony health. Beekeepers are faced with an often difficult choice between utilizing chemical interventions to treat their hives for mites or risking colony loss due to the stress caused by overwhelming mite populations. The results of this study suggest that the use of *tau*-fluvalinate and coumaphos, while reducing stress due to mite feeding, may increase nutritional stress and decrease the effectiveness of select social immune responses, though more work is needed to evaluate the long-term impact of these changes.
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